Clinical trial
Busulfan Plus Melphalan Conditioning Regimen for Lymphoid Malignancies or…
NCT00427765 · M.D. Anderson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00427765 |
|---|---|
| Title | Busulfan Plus Melphalan Conditioning Regimen for Lymphoid Malignancies or Multiple Myeloma |
| Official title | A Phase II Study of High-Dose Intravenous Busulfan Plus Melphalan With Allogeneic or Autologous Marrow or Peripheral Blood Progenitor Cell Transplantation for Lymphoid Malignancies or Multiple Myeloma |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Multiple Myeloma, Lymphoma |
| Intervention type | Drug |
| Interventions | Busulfan, Melphalan |
| Enrollment | 168 |
| Start date | Dec 1, 2004 |
| Primary completion | Nov 1, 2010 |
| Completion | Nov 1, 2010 |
| First posted | Jan 29, 2007 |
| Last update posted | Jan 19, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: